ScreenerHero vs Morningstar
Morningstar is built for fund analysis.
We're built for stock screening.
Morningstar Premium is excellent for fund research, analyst reports, and Economic Moat ratings. If you primarily screen stocks — especially European equities — ScreenerHero covers US, Canada, Europe & Australia in a screening-first tool with a free tier and a one-time paid plan.
Morningstar Premium
$21/mo
ScreenerHero Lifetime
97€ once · no subscription
Updated October 2026 · Honest comparison, including where Morningstar is genuinely better
After about 5 months, Morningstar Premium has cost you more than ScreenerHero Lifetime (97€, once).
Free screener: no signup, no credit card. Lifetime: no subscription, 30-day money-back guarantee.
Which is better, ScreenerHero or Morningstar?
It depends on funds versus stocks. Morningstar is the better choice for fund research, star ratings, analyst reports and Economic Moat ratings. ScreenerHero is a stock screener: filters across the US, Canada, Europe and Australia, microcaps included, a free tier, and a one-time paid plan. Its Moat Score is a formula on reported metrics, not an analyst rating. Choose Morningstar for analyst opinion, ScreenerHero for your own filters.
At a glance
| Feature | ScreenerHero | Morningstar |
|---|---|---|
| US stock coverage | Strong: Full NYSE, NASDAQ, NYSE American | Strong: Yes — strong analyst coverage on large and mid-cap US equities |
| Canadian stock coverage | Strong: Yes — TSX and TSXV in the same screener | Weak or absent: Limited — not a screener-grade focus |
| European stock coverage | Strong: All major European exchanges including microcaps | Weak or absent: Some coverage but European screener depth is weak |
| Stock screener | Strong: Filter-first — P/E, P/B, ROE, EV/EBITDA, margins, beta, momentum | Partial: Basic screener — fewer filter options, US-weighted results |
| Fund & ETF analysis | Partial: Basic list only — price and performance, no ratings or X-ray | Strong: Best in class — star ratings, analyst coverage, X-ray portfolio tool |
| Analyst reports | Partial: Not included — only analyst consensus targets, ratings and estimates | Strong: Yes — proprietary analyst reports on covered stocks |
| Moat / Fair value ratings | Partial: A formula-based Moat Score from reported ROE, margins and debt on each quote page — not an analyst rating, and no Fair Value estimates | Strong: Yes — Economic Moat ratings, Fair Value estimates per stock |
| Price | Partial: Free screener, no account needed · Lifetime: 97€ once, no subscription | Strong: $249/year (~$21/mo, ≈€19/mo) — limited free tier |
| Free tier | Strong: Yes — full screener, no account required | Weak or absent: Very limited — most data paywalled |
| UI focus | Strong: Desktop-first screener — dense, filter-driven | Partial: Research portal — comprehensive per-stock pages, not screener-optimised |
Seen enough? Try it on your own criteria.
Free screener: no signup, no credit card. Lifetime: no subscription, 30-day money-back guarantee.
Where the differences actually matter
Stock screener depth
Morningstar's screener is secondary to its research portal. Filter options are limited compared to dedicated screening tools, and results are weighted towards large-cap US equities where Morningstar has analyst coverage.
ScreenerHero is built entirely around the screener. Filters include P/E, P/B, P/S, EV/EBITDA, ROE, margins, beta, dividend yield, momentum, and more — applied simultaneously across US, Canadian, European & Australian stocks in one query.
European and microcap coverage
Morningstar covers some European stocks but continental small caps and microcaps are not a focus. Illiquid names on Euronext Growth, BME Growth, or First North are often missing or have sparse data.
ScreenerHero covers all active instruments on major European exchanges including microcaps. European coverage — including illiquid names most platforms skip — is a first-class feature.
Analyst reports vs raw metrics
Morningstar's proprietary analyst reports and Economic Moat ratings are one of the most respected research frameworks in the industry. If you want external analyst consensus integrated into your workflow, that is Morningstar's core value.
ScreenerHero exposes raw metrics — P/E, P/B, ROE, and the rest — plus one formula-based Moat Score on each quote page, computed from reported ROE, margins and debt. It is not an analyst rating. If you build your own investment framework and want to apply it across a large universe fast, raw data is what you need.
ScreenerHero is the better fit if…
- Investors who screen stocks rather than funds or ETFs
- Anyone covering European small and microcap names most platforms skip
- Analysts who build their own criteria and want raw metrics across US, Canada, Europe & Australia
- Users who want a screener-first tool without paying for analyst reports they don't use
- Investors who want Canadian stocks included alongside US and European names
Morningstar is the better fit if…
- Fund and ETF investors who rely on Morningstar's star rating system
- Investors who want proprietary analyst reports and Fair Value estimates
- Portfolio analysts who use the X-ray tool to see underlying holdings
- US-focused equity researchers who value Morningstar's Economic Moat framework
Try the screener for free
Filter US, Canadian, European & Australian stocks by P/E, ROE, EV/EBITDA, and more. No account needed to start.
Free screener: no signup, no credit card. Lifetime: no subscription, 30-day money-back guarantee.